SPCC594.03 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

The SPCC594.03 Antibody (Catalog No. CSB-PA529189XA01SXV) is a polyclonal antibody specifically designed for research applications targeting the O74506 protein in Schizosaccharomyces pombe (fission yeast). This antibody is part of a broader portfolio of fission yeast-specific antibodies developed for studying cellular processes, protein localization, and functional analysis in yeast models .

Target Protein Overview

The antibody recognizes a protein encoded by the SPCC594.03 gene in S. pombe. While detailed functional annotations for this gene are not explicitly provided in the available sources, its predicted role aligns with conserved yeast proteins involved in cellular homeostasis or metabolic regulation. Proteins in this category often participate in stress response pathways, mitochondrial function, or cytoskeleton organization, as inferred from homology with characterized yeast orthologs .

Applications

The antibody is validated for:

  • Western Blot (WB): Detects a single band corresponding to the O74506 protein in lysates of S. pombe cells .

  • Immunofluorescence (IF): Localizes the target protein to subcellular compartments, likely cytoplasmic or mitochondrial based on yeast protein localization patterns .

  • Potential Use in IP: While not explicitly tested, polyclonal antibodies like this are often suitable for immunoprecipitation (IP) to isolate protein complexes .

Validation and Specificity

The antibody undergoes rigorous quality control, including:

  • Target-specific validation: Tested against lysates of S. pombe to ensure no cross-reactivity with non-target proteins .

  • Species specificity: Designed exclusively for S. pombe (strain 972/ATCC 24843), minimizing cross-reactivity with other yeasts or eukaryotes .

Research Context

This antibody contributes to studies of yeast cellular biology, complementing tools like the Antibody Validation Database (e.g., Figure 1 in ) and PLAbDab (a repository of antibody sequences and structures) . While SPCC594.03 is not listed in these databases, its design aligns with best practices for antibody validation, including knockout (KO) cell line testing and epitope mapping .

Limitations and Future Directions

  • Lack of structural data: No crystallographic or sequence-based annotations (e.g., CDR regions) are available for this antibody .

  • Cross-reactivity: In silico analysis (e.g., BLAST/SIM scores) could confirm species specificity, though experimental data are currently limited .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPCC594.03 antibody; Uncharacterized protein C594.03 antibody
Target Names
SPCC594.03
Uniprot No.

Q&A

What is SPCC594.03 Antibody and what is its target protein?

SPCC594.03 Antibody (catalog number CSB-PA529189XA01SXV) is a polyclonal antibody specifically designed for research applications targeting the O74506 protein encoded by the SPCC594.03 gene in Schizosaccharomyces pombe (fission yeast strain 972/ATCC 24843). The antibody recognizes epitopes on this protein, which is believed to be involved in cellular homeostasis or metabolic regulation based on homology with characterized yeast orthologs.

What applications has SPCC594.03 Antibody been validated for?

The antibody has been validated for:

  • Western Blot (WB): Detects a single band corresponding to the O74506 protein in lysates of S. pombe cells

  • Immunofluorescence (IF): Enables localization of the target protein to subcellular compartments

  • Potential use in Immunoprecipitation (IP): While not explicitly tested, its polyclonal nature makes it likely suitable for isolating protein complexes

What is the composition and formulation of SPCC594.03 Antibody?

The antibody is supplied in a buffer containing:

  • Preservative: 0.03% Proclin 300

  • Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4

This formulation helps maintain antibody stability during storage and handling.

How should I design experiments to validate SPCC594.03 Antibody specificity?

To validate antibody specificity in your experimental system, implement a multi-step approach:

  • Western blot validation: Run lysates from wild-type S. pombe alongside a negative control (ideally a SPCC594.03 gene knockout strain if available). A specific antibody will show a band at the expected molecular weight in wild-type but not in knockout samples .

  • Mass spectrometry validation: Perform immunoprecipitation with the antibody followed by mass spectrometry to identify all proteins captured. This approach can determine if the antibody binds to its intended target among thousands of other cellular components .

  • Sequence homology analysis: Use NCBI-BLAST to assess the target protein's sequence homology with other proteins within the proteome to predict potential cross-reactivity .

  • Immunofluorescence pattern analysis: Compare the subcellular localization pattern with published data or predicted localization based on protein function.

What controls should I include when using SPCC594.03 Antibody?

Always include appropriate controls to ensure experimental validity:

Control TypePurposeImplementation
Positive ControlConfirms antibody activityUse wild-type S. pombe (strain 972/ATCC 24843) lysate
Negative ControlTests for non-specific bindingUse lysate from cells where the target is not expressed or knockout cells
Secondary Antibody OnlyDetects non-specific binding of secondary antibodyOmit primary antibody but include all other reagents
Isotype ControlIdentifies non-specific binding due to antibody classUse non-specific antibody of same isotype and concentration
Blocking Peptide ControlConfirms epitope specificityPre-incubate antibody with excess antigen before application

How can I optimize Western blot protocols for SPCC594.03 Antibody?

For optimal Western blot results with SPCC594.03 Antibody:

  • Sample preparation:

    • Lyse S. pombe cells in a buffer containing protease inhibitors to prevent protein degradation

    • Include phosphatase inhibitors if phosphorylation status is important

    • Denature samples at 95°C for 5 minutes in sample buffer containing SDS and reducing agent

  • Gel electrophoresis and transfer:

    • Use an appropriate percentage acrylamide gel based on target protein size

    • Ensure complete transfer to membrane using a transfer control stain

  • Antibody application:

    • Block membrane thoroughly (5% non-fat milk or BSA in TBST)

    • Start with 1:1000 dilution of SPCC594.03 Antibody and optimize as needed

    • Incubate overnight at 4°C for best results

    • Wash extensively with TBST between antibody applications

  • Detection:

    • Use an appropriate HRP-conjugated secondary antibody

    • Develop using enhanced chemiluminescence with exposure times optimized for signal-to-noise ratio

Will SPCC594.03 Antibody cross-react with proteins from other organisms?

The SPCC594.03 Antibody was designed specifically for S. pombe (strain 972/ATCC 24843). Cross-reactivity with proteins from other organisms depends on sequence homology:

  • High probability of cross-reactivity (>75% sequence homology with immunogen)

  • Moderate probability of cross-reactivity (60-75% sequence homology)

  • Low probability of cross-reactivity (<60% sequence homology)

To predict cross-reactivity with a specific organism of interest:

  • Obtain the amino acid sequence of SPCC594.03 protein

  • Perform BLAST alignment against the proteome of your organism of interest

  • Calculate sequence homology percentages, particularly in immunogenic regions

  • Experimentally validate any predicted cross-reactivity

How can I assess if SPCC594.03 Antibody recognizes specific post-translational modifications?

Determining if an antibody recognizes specific post-translational modifications (PTMs) requires specialized approaches:

  • Parallel analysis with PTM-specific antibodies: Run samples on parallel blots and probe with both SPCC594.03 Antibody and antibodies specific to common PTMs (phosphorylation, acetylation, etc.)

  • Enzyme treatment: Treat samples with enzymes that remove specific PTMs (e.g., phosphatases, deacetylases) and assess if this affects antibody recognition

  • Mass spectrometry analysis: After immunoprecipitation with SPCC594.03 Antibody, analyze pulled-down proteins using mass spectrometry with PTM detection capabilities

  • In vitro modification: Compare antibody recognition of recombinant proteins with and without specific PTMs

Can SPCC594.03 Antibody be used for studying meiotic processes in S. pombe?

The SPCC594.03 Antibody may be valuable for studying meiotic processes in S. pombe, particularly if the target protein has a role in meiosis. Meiotic research applications could include:

  • Temporal expression analysis: Western blotting to detect changes in protein expression levels throughout meiotic progression

  • Localization studies: Immunofluorescence to track protein localization during different meiotic stages (leptotene, zygotene, pachytene, etc.)

  • Protein interaction investigations: Immunoprecipitation coupled with mass spectrometry to identify interaction partners specific to meiotic contexts

When designing meiotic studies with this antibody, consider the approaches used in similar research such as characterization of HOP1 and SUN1 proteins in planarian spermatogenesis, which revealed their essential roles in homolog pairing, synapsis, and bouquet formation during meiotic prophase .

How can I use SPCC594.03 Antibody in combination with other antibodies for complex protein interaction studies?

For multi-protein interaction studies:

  • Sequential immunoprecipitation:

    • Perform primary IP with SPCC594.03 Antibody

    • Elute under mild conditions

    • Perform secondary IP with antibody against suspected interaction partner

    • Analyze final precipitate for enrichment of both proteins

  • Co-immunofluorescence:

    • Use SPCC594.03 Antibody with antibodies against other proteins of interest

    • Select secondary antibodies with non-overlapping fluorophores

    • Analyze co-localization using confocal microscopy and quantitative co-localization metrics

  • Proximity ligation assay (PLA):

    • Apply SPCC594.03 Antibody with antibody against potential interaction partner

    • Use species-specific PLA probes

    • Visualize interactions as fluorescent spots only when proteins are within 40nm of each other

What approaches can I use to incorporate SPCC594.03 Antibody into quantitative proteomics workflows?

SPCC594.03 Antibody can be integrated into quantitative proteomics workflows through several approaches:

  • Immunoprecipitation followed by mass spectrometry (IP-MS):

    • Use SPCC594.03 Antibody to capture protein complexes

    • Process samples for MS analysis following established protocols

    • Quantify relative abundance of interacting proteins using label-free or labeled approaches

  • Selected reaction monitoring (SRM) or parallel reaction monitoring (PRM):

    • Develop targeted MS assays for O74506 protein and its interactors

    • Use antibody-based enrichment to improve sensitivity

  • Absolute quantification:

    • Use SPCC594.03 Antibody in western blots alongside a standard curve of recombinant target protein

    • Correlate band intensity with known protein quantities for absolute quantification

What are common issues when using SPCC594.03 Antibody and how can they be resolved?

IssuePossible CausesSolutions
No signalAntibody degradation; Target not expressed; Incorrect secondary antibodyUse fresh aliquot; Confirm target expression; Verify secondary antibody compatibility
High backgroundInsufficient blocking; Too high antibody concentration; Non-specific bindingOptimize blocking conditions; Titrate antibody; Include 0.1-0.3% Triton X-100 in wash buffers
Multiple bandsCross-reactivity; Protein degradation; Post-translational modificationsInclude protease inhibitors; Validate with knockout controls; Perform peptide competition
Weak signalLow target abundance; Insufficient incubation time; Inefficient transferIncrease sample loading; Extend incubation time; Optimize transfer conditions
Inconsistent resultsBatch-to-batch variation; Protocol inconsistenciesUse same antibody lot; Standardize protocols; Include positive controls

How should SPCC594.03 Antibody be stored and handled to maintain optimal activity?

For optimal preservation of antibody activity:

  • Storage conditions:

    • Store at -20°C for long-term storage

    • Avoid repeated freeze-thaw cycles by preparing single-use aliquots

    • Keep in the supplied buffer containing 50% glycerol

  • Handling recommendations:

    • Thaw aliquots on ice

    • Centrifuge briefly before opening to collect liquid at the bottom

    • Use sterile technique when handling to prevent contamination

    • Return to -20°C immediately after use

  • Working solution preparation:

    • Dilute in fresh, cold buffer immediately before use

    • Do not store diluted antibody for extended periods

    • Include 0.1% sodium azide in working solutions if they must be stored (not for HRP applications)

How can I validate the batch-to-batch consistency of SPCC594.03 Antibody?

To ensure consistent performance across different antibody batches:

  • Standardized validation protocol:

    • Develop a reference Western blot protocol with standard samples

    • Generate a reference blot image with the current working batch

    • Test each new batch against the same samples and compare results

  • Key parameters to compare:

    • Signal intensity at standard dilution

    • Background levels

    • Specificity (absence of non-specific bands)

    • Sensitivity (detection limit)

  • Documentation and record-keeping:

    • Maintain detailed records of batch numbers and performance

    • Document any variations observed between batches

    • Adjust protocols as needed based on batch characteristics

Could SPCC594.03 Antibody be adapted for use in engineered biological systems?

While the SPCC594.03 Antibody is currently validated for detecting the native O74506 protein in S. pombe, it could potentially be adapted for use in engineered systems:

  • Recombinant expression systems:

    • Could detect O74506 protein expressed in other systems (E. coli, mammalian cells)

    • Useful for verifying successful heterologous expression

  • Tagged protein detection:

    • May recognize epitopes on tagged versions of the target protein

    • Could be used alongside tag-specific antibodies for confirmation

  • Comparative studies:

    • Could detect orthologs in engineered strains of related yeast species if sufficient homology exists

Similar to how researchers developed fluorescent strains of Treponema pallidum for tracking host-pathogen interactions , the SPCC594.03 Antibody could potentially be used to track engineered versions of its target protein.

What are the potential applications of SPCC594.03 Antibody in studying cellular stress responses?

If the O74506 protein is involved in stress response pathways in S. pombe, the SPCC594.03 Antibody could be instrumental in:

  • Stress-induced expression changes:

    • Monitor protein levels in response to various stressors (oxidative, osmotic, nutrient)

    • Track temporal changes during stress exposure and recovery

  • Stress-dependent relocalization:

    • Use immunofluorescence to monitor changes in subcellular localization during stress

    • Correlate localization changes with functional outcomes

  • Stress-specific interactions:

    • Identify stress-specific protein interaction partners through comparative IP-MS

    • Characterize how these interactions contribute to stress adaptation

  • Post-translational modifications:

    • Investigate stress-induced modifications that may alter antibody recognition

    • Correlate modifications with protein function during stress response

This application would be particularly relevant if the protein has functional similarities to other stress-response proteins in yeast.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.